Abstract
The inflammatory bowel diseases (IBD), Crohn’s disease (CD), and ulcerative colitis (UC), are complex multifactorial traits involving both environmental and genetic factors. Mannan-binding lectin (MBL) plays an important role in non-specific immunity and complement activation. Point mutations in codons 52, 54 and 57 of exon 1 of the MBL gene are associated with decreased MBL plasma concentrations and increased susceptibility to various infectious diseases. If these MBL mutations could lead to susceptibility to putative IBD-etiological microbial agents, or could temper the complement-mediated mucosal damage in IBD, MBL could function as the link between certain microbial, immunological and genetic factors in IBD. In this study, we investigated the presence of the codon 52, 54 and 57 mutations of the MBL gene in 431 unrelated IBD patients, 112 affected and 141 unaffected first-degree relatives, and 308 healthy control individuals. In the group of sporadic IBD patients (n = 340), the frequency of the investigated MBL variants was significantly lower in UC patients when compared with CD patients (P = 0.01) and with controls (P = 0.02). These results suggest that MBL mutations which decrease the formation of functional MBL could protect against the clinical development of sporadic UC, but not of CD. This could be explained by the differential T-helper response in both diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Binder V Genetic epidemiology in inflammatory bowel disease Dig Dis 1998 16 351–355
Calkins BM, Mendelhoff AI The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG (eds). Inflammatory Bowel Disease 1995 Williams & Wilkins: Baltimore 1995 pp 31–68
Satsangi J, Rosenberg W, Jewell DP The prevalence of inflammatory bowel disease in relatives of patients with Crohn’s disease Eur J Gastroenterol Hepatol 1994 6 413–416
Peeters M, Nevens H, Baert F et al Familial aggregation in Crohn’s disease: increased age-adjusted risk and concordance in clinical characteristics Gastroenterology 1996 111 597–603
Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking Gut 1988 29 990–996
Turner MW Mannose-binding lectin: the pluripotent molecule of the innate immune system Immunol Today 1996 17 532–540
Thiel SS, Vorup-Jensen T, Stover CM et al A second serine protease associated with mannan-binding lectin that activates complement Nature 1997 386 506–510
Kuhlman M, Joiner K, Ezekowitz RAB The human mannose-binding protein functions as an opsonin J Exp Med 1989 169 1733–1745
Sumiya M, Super M, Tabona P et al Molecular basis of opsonic defect in immunodeficient children Lancet 1991 337 1569–1570
Libscombe RJ, Sumiya M, Hill AV et al High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene Hum Mol Genet 1992 1 709–715
Madsen HO, Garred P, Kurtzhals JA et al A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein Immunogenetics 1994 40 37–44
Super M, Thiel S, Lu J, Levinsky RJ, Turner MW Association of low levels of mannose-binding protein with a common defect of opsonization Lancet 1989 ii 1236–1239
Summerfield JA, Ryder S, Sumiya M et al Mannose binding protein gene mutations associated with unusual and severe infections in adults Lancet 1995 345 886–889
Sartor RB Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease Gastroenterol Clin North Am 1995 24 475–507
Wakefield AJ, Sim R, Akbar AN, Pounder RE, Dillon AP In situ immune responses in Crohn’s disease: a comparison with acute and persistent measles virus infection J Med Virol 1997 41 90–100
Ardizzone S, Bollani S, Manzionna G, Bianchi Porro G Inflammatory bowel disease approaching the 3rd millenium pathogenesis and therapeutic implications? Eur J Gastroenterol Hepatol 1999 11 27–32
Garred P, Madsen HO, Hoffmann B, Svejgaard A Increased frequency of homozygosity of abnormal mannan-binding protein alleles in patients with suspected immunodeficiency Lancet 1995 346 941–943
Turner MW Mannose-binding lectin (MBL) in health and disease Immunobiology 1998 199 327–339
Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn’s disease Gut 2000 46 58–63
Vermeire S, Peeters M, Vlietinck R et al Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families Inflamm Bowel Dis 2001 7 8–15
Ahrenstedt Ö, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hällgren R Enhanced local production of complement components in the small intestines of patients with Crohn’s disease N Engl J Med 1990 322 1345–1349
Halstensen TS, Mollnes TE, Brandtzaeg P Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence Gastroenterology 1989 97 10–19
Ueki T, Mizuno M, Uesu T et al Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC) Clin Exp Immunol 1996 104 286–292
Dube R, Rook GA, Steele J et al Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein Gut 1990 31 431–434
Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein Nat Med 1995 1 237–243
Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A Dual role of mannan-binding protein in infections: another case of heterosis Eur J Immunogenet 1994 21 125–131
Höhler T, Wünschel M, Gerken G, Schneider PM, Meyer zum Büschenfelde K-H, Rittner C No association between mannose-binding lectin alleles and susceptibility to chronic hepatitis B virus infection in German patients Exp Clin Immunogenet 1998 15 130–133
Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC Detection of structural gene mutations and promotor polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers J Immunol Methods 2000 241 33–42
Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P Association of mannose-binding-lectin deficiency with severe atherosclerosis Lancet 1998 352 959–960
Zeitz M Pathogenesis of inflammatory bowel disease Digestion 1997 58 59–61
Sartor RB Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases Am J Gastroenterol 1997 92 5S–11S
Arai T, Tabona P, Summerfield JA Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock Q J Med 1993 86 575–582
Madsen HO, Garred P, Thiel S et al Interplay between promotor and structural gene variants control basal serum levels of mannan-binding protein J Immunol 1995 155 3013–3020
Lennard-Jones JE Classification of inflammatory bowel disease Scand J Gastroenterol 1989 170 (Suppl) 2–6; discussion pp 16–19
World Medical Association World Medical Association’s Declaration of Helsinki 1964 World Medical Association 1996 Fernay-Voltaire(http://www.wma.net)
Miller SA, Dykes DD, Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 1988 16 1215
Lench N, Stanier P, Williamson R Simple non-invasive method to obtain DNA for gene analysis Lancet 1988 1 1356–1358
De Roda Husman AM, Koot M, Cornelissen M et al Association between CCR5 genotype and the clinical course of HIV-1 infection Ann Intern Med 1997 127 882–890
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by a grant of the Fund for Scientific Research (FWO), Brussels, Belgium. S Vermeire is a fellow of the FWO Belgium. P Lemey was supported by a grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen). F Struyf was supported by a grant from the Belgian American Educational Foundation (BAEF) and the Collen Research Foundation.
Rights and permissions
About this article
Cite this article
Rector, A., Lemey, P., Laffut, W. et al. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn’s disease . Genes Immun 2, 323–328 (2001). https://doi.org/10.1038/sj.gene.6363784
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363784
Keywords
This article is cited by
-
Association of mannose binding lectin with chronic obstructive pulmonary disease susceptibility and its clinical outcomes
Molecular Biology Reports (2023)
-
Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease?
Immunogenetics (2010)
-
Increased Risk of Both Ulcerative Colitis and Crohn’s Disease in a Population Suffering from COPD
Lung (2008)
-
Serum Mannan-Binding Lectin Levels in Patients with Celiac Disease: An Analysis of Clinical and Autoimmune Features
Digestive Diseases and Sciences (2007)
-
Association of a new mannose-binding lectin variant with severe malaria in Gabonese children
Genes & Immunity (2006)